During ischemia, the myocardial content of the purine nucleotides ATP and GTP falls and remains depressed for hours to days. Prolonged depletion of ATP in the postischemic state is accompanied by functional and ultrastructural abnormalities. This report describes the successful use of the purine precursor 5-aminoimidazole-4-carboxamide riboside to selectively enhance the rate of repletion of the ATP and GTP pools in postischemic myocardium. (Ore Res 51: 102-105, 1982) 
SUMMARY. During ischemia, the myocardial content of the purine nucleotides ATP and GTP falls and remains depressed for hours to days. Prolonged depletion of ATP in the postischemic state is accompanied by functional and ultrastructural abnormalities. This report describes the successful use of the purine precursor 5-aminoimidazole-4-carboxamide riboside to selectively enhance the rate of repletion of the ATP and GTP pools in postischemic myocardium. (Ore Res 51: 102-105, 1982) DURING brief periods of ischemia (i.e., <15 min), myocardial content of creatine phosphate (CP), ATP, GTP, UTP, CTP, and NAD + falls (Vial et al., 1978; Kloner et al., 1981; Swain et al., 1982) . With reperfusion, CP content is restored to normal or supranormal levels within 1-5 minutes (Vial et al., 1978; Swain et al., 1982) , indicating that energy metabolism is not impaired in postischemic myocardium. In contrast, all of the purine, pyrimidine, and pyridine nucleotide pools remain depressed for hours to days before returning to control levels (Vial et al., 1978; Kloner et al., 1981; Swain et al., 1982) . The close temporal association between the prolonged time required for repletion of nucleotide pools and delayed recovery of functional and ultrastructural abnormalities in previously ischemic myocardium (Kloner et al., 1981) suggests that depletion of one or more of these nucleotide pools may play a role in the functional abnormalities noted in postischemic myocardium.
Another conclusion that has been drawn from the studies cited above is that the basis for the slow rate of repletion of the ATP and GTP pools is the loss of purines from the myocardium in the form of adenosine, inosine, and hypoxanthine during reperfusion (Swain et al., 1982) . This loss of purine, coupled with the limited capacity of the heart for de novo purine synthesis (Zimmer et al., 1973) , may explain the prolonged time required for repletion of the ATP and GTP pools. It is not clear whether delayed repletion of the other nucleotide pools is due to loss of pyrimidines and pyridines or whether it is the result of delayed ATP repletion, since synthesis of all other nucleotides depends upon ATP availability.
The hypotheses to be tested are that limited availability of purine precursor is responsible for the delayed repletion of ATP and GTP pools in postischemic myocardium and that delayed repletion of these, as well as other, nucleotide pools is responsible for the prolonged functional abnormalities noted in postischemic myocardium. Therefore, one needs to be able to administer an agent which specifically and selectively affects the rate of purine nucleotide synthesis in myocardium. This report describes the successful use of a purine precursor, 5-aminoimidazole-4-carboxamide riboside (AICAriboside), to enhance the rate of repletion of the ATP and GTP pools in postischemic myocardium. A prior report from this laboratory describes in detail the metabolism of AI-CAriboside in normal myocardium (Sabina et al., 1982) .
Methods
Catheters were placed in the left atrium and aorta, and a snare positioned around the left anterior descending coronary artery in 15 open-chest dogs as previously described (Swain et al., 1982) . Regional myocardial blood flow was measured and transmural tissue samples were obtained by the techniques previously reported (Swain et al., 1982) . Blood flow measurements and tissue samples were obtained prior to and just before release of a 12-minute coronary occlusion. The chest was closed and the animals allowed to awaken. Twenty-four hours later, the animals were anesthetized, the chest opened, blood flow measured, and tissue samples obtained. No hemodynamic measurements were made on the animals.
In seven animals, 200 mM AICAriboside (Sigma Chemical Co.) was infused into the left atrial catheter at either 14 jumol/min (n = 2) or 37 /nmol/min (n = 5) beginning with coronary occlusion and continuing for 24 hours. Eight control animals were infused with an equal volume of saline over 24 hours.
Nucleotide (Sabina et al., 1982) and creatine phosphate (Juengling and Kammermeier, 1980) analyses were performed by high performance liquid chromatography on acid extracts of the tissue as previously described. All values are reported as the mean ± SEM. Comparison of the AICAriboside to saline-treated at each time point revealed no significant differences.
All comparisons between AICAriboside and salinetreated animals were done by unpaired analyses.
Results
There were no differences in regional flow at any time point when the AICAriboside-treated group was compared to the saline group (Table 1) . The mean ischemic flow in the AICAriboside group was slightly but not significantly higher than the saline group due to one animal with higher ischemic and nonischemic area flows. The presence of a reactive hyperemic response in all animals indicated no mechanical impediment to reperfusion.
AICAriboside was transported into postischemic cardiac myocytes and phosphorylated as evidenced by the accumulation of 0.069 ± 0.016 and 0.076 ± 0.008 jumol/g at 24 hr of the ribotide of AICAriboside (AICAR) in epicardium and endocardium of the pre-viously ischemic region. No AICAR was detectable in preocclusion samples from either group nor in any of the biopsies obtained from the saline-treated group.
AICAR was metabolized to IMP in postischemic as well as normal myocardium, as evidenced by the 3to 6-fold increase in IMP at 24 hours in both of these regions in the AICAriboside-treated group (Table 2) . IMP content did not change in either the postischemic or nonischemic regions over the course of the study in saline-treated animals ( Table 2 ). The ATP content of myocardium in the AICAriboside and salinetreated groups is shown for all time points in Figure  1 . ATP content of the preocclusion samples and the percentage drop in ATP during ischemia were comparable in both groups. After 24 hours of reperfusion, both the epicardial and endocardial ATP content of the previously ischemic region was greater in the AICAriboside group when compared to the salinetreated animals (P < 0.001). This represents a 41%
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Preocclusion AICAriboside Saline (epi) and 63% (endo) increase in the AICAriboside group compared with only a 2% (epi) and 21% (endo) increase in the saline-treated group. Total adenine nucleotide content (ATP+ADP+AMP) of the postischemic region was also greater in the AICAriboside group, with no detectable differences in AMP or ADP content between the two groups (Table 2) . Changes in the GTP pools paralleled those seen in the ATP pools (Fig. 2) . After 24 hours of reperfusion, the GTP content of the previously ischemic region was greater in the AICAriboside group in both the epicardium and endocardium (P < 0.003) when compared with the saline-treated group. GTP content was restored to nonischemic levels in the AICAriboside group, while guanine nucleotide pools remained depressed at 82% (epi) and 78% (endo) of nonischemic levels in the saline-treated group.
It is less clear whether AICAriboside administration had any effect on the rate of repletion of the pyrimidine and pyridine nucleotide pools in postischemic myocardium because of the more rapid rate of repletion of both these classes of nucleotides, relative to that of the purine nucleotides, in the saline-treated group (Table 2) . Whereas there were no statistically significant differences between the two groups with respect to UTP, CTP, or NAD + content of myocar- dium from the postischemic region, samples from earlier time points are needed to exclude an effect of AICAriboside administration on the rate of repletion of these nucleotide pools. Creatine phosphate content fell to a comparable extent at the end of occlusion in both groups and was restored to preocclusion levels in the postischemic regions in both groups (Table 2 ).
Discussion
Previous work from this laboratory has shown that AICAriboside is taken up rapidly by myocardial cells, and is readily phosphorylated and metabolized to purine nucleotides in these cells (Sabina et al., 1982) . One advantage offered by this precursor is that it enters the de novo pathway distal to the critical regulatory reactions and, consequently, it can markedly increase the rate of purine nucleotide synthesis (Thomas et al., 1981; Sabina et al., 1982) . In animals with normal myocardial nucleotide pools, there is limited expansion of the ATP and GTP pools following AICAriboside administration, the majority of newly synthesized IMP being diverted out of the cell through catabolic pathways. In the present study we demonstrate that this purine precursor is capable of enhancing the rate of repletion of the ATP and GTP pools in postischemic myocardium. The effectiveness of this precursor in expanding purine nucleotide pools is related to an enhanced rate of IMP formation coupled with diversion of a greater proportion of newly synthesized IMP into adenylate and guanylate pools. The diversion of IMP to ATP and GTP synthesis may be the result of either a release of feedback inhibition secondary to nucleotide depletion, or to a slower rate of AICAriboside infusion, compared to the previous study, resulting in a smaller accumulation of AICAR, a known inhibitor of adenylosuccinate lyase (Sabina et al., 1982) .
AICAriboside has additional properties which are useful in delineating the mechanism by which it enhances the rate of repletion of the ATP and GTP pools. The finding that the AICAR and IMP content of the myocardium increases after AICAriboside administration establishes the increased availability of precursors for ATP and GTP synthesis in these cells. This, coupled with the finding of an enhanced rate of repletion of the ATP and GTP pools following AI-CAriboside administration, documents that limited availability of purine precursor is responsible for the prolonged period required for repletion of these nucleotide pools in postischemic myocardium.
Having established the basis for delayed repletion of nucleotide pools following ischemia, it is now possible to address the related question of the role of nucleotide depletion in the prolonged functional ab-normalities^ noted in post-ischemic myocardium (Kloner et al., 1981) . AICAriboside should be a useful tool in answering this question, since it represents a specific and selective method for enhancing the rate of purine nucleotide synthesis in myocardium. Results of such a study should be easily interpretable, since the administration of AICAriboside in doses which are demonstrated to replete nucleotide pools does not alter the hemodynamic state of the animal or regional myocardial blood flow.
